プレミアアンチエイジング(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 化学 | 4934/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/04/05 | 日証協 | 830,296株 | +2.76% | 168,333株 | +11.69% | 745,846株 | +4.28% | 61,442株 | +88.47% |
2024/03/29 | 日証協 | 807,971株 | -4.18% | 150,708株 | +46.32% | 715,244株 | -0.61% | 32,600株 | -11.9% |
2024/03/22 | 日証協 | 843,203株 | +3.36% | 103,000株 | -76.55% | 719,644株 | +3.63% | 37,003株 | -21.1% |
2024/03/15 | 日証協 | 815,779株 | -0.66% | 439,240株 | +236.84% | 694,417株 | +0.23% | 46,900株 | +37.94% |
2024/03/08 | 日証協 | 821,171株 | +3.06% | 130,400株 | -23.07% | 692,817株 | -1.12% | 34,000株 | +3.34% |
2024/03/01 | 日証協 | 796,771株 | -4.73% | 169,508株 | -43.07% | 700,641株 | +0.09% | 32,900株 | +47.5% |
2024/02/22 | 日証協 | 836,306株 | -9.01% | 297,762株 | -16.65% | 700,036株 | -5.35% | 22,305株 | -35.53% |
2024/02/16 | 日証協 | 919,162株 | +10.31% | 357,252株 | -10.85% | 739,612株 | +1.9% | 34,600株 | +44.77% |
2024/02/09 | 日証協 | 833,263株 | -1.13% | 400,751株 | -7.94% | 725,812株 | -0.14% | 23,900株 | -53.95% |
2024/02/02 | 日証協 | 842,756株 | +4.23% | 435,294株 | +1.12% | 726,812株 | +2.5% | 51,900株 | +68.51% |
2024/01/26 | 日証協 | 808,557株 | -2.12% | 430,486株 | +7.56% | 709,112株 | +3.8% | 30,800株 | -30.18% |
2024/01/19 | 日証協 | 826,067株 | -1.27% | 400,231株 | -15.69% | 683,121株 | -2.16% | 44,111株 | -45.27% |
2024/01/12 | 日証協 | 836,668株 | +12.81% | 474,713株 | +235.24% | 698,210株 | -0.35% | 80,600株 | +303% |
2024/01/05 | 日証協 | 741,647株 | -2.07% | 141,606株 | -18.02% | 700,634株 | +0.27% | 20,000株 | -45.36% |
2023/12/29 | 日証協 | 757,331株 | -11.71% | 172,741株 | -23.97% | 698,734株 | -6.26% | 36,604株 | -30.55% |
2023/12/22 | 日証協 | 857,736株 | +5.79% | 227,207株 | -52.95% | 745,434株 | +4.4% | 52,707株 | +2.34% |
2023/12/15 | 日証協 | 810,826株 | +6.3% | 482,863株 | +887.93% | 714,034株 | +2% | 51,500株 | +103.56% |
2023/12/08 | 日証協 | 762,755株 | +1.36% | 48,876株 | +623.66% | 700,034株 | -1.53% | 25,300株 | +184.27% |
2023/12/01 | 日証協 | 752,547株 | -2.83% | 6,754株 | -74.53% | 710,884株 | -2.63% | 8,900株 | -27.64% |
※株式分割は考慮していませんのでご注意ください。
Page Top